Placeholder text

Go to cart

Liver elastography in patients with hepatocellular carcinoma

By Lucas S. Nacif

Liver elastography in patients with hepatocellular carcinoma Medicine

Liver elastography in patients with hepatocellular carcinoma

0 - Default Title
Description
Cirrhosis is the eighth leading cause of death worldwide, and its progression and staging are extremely important in patients with end-stage liver disease. The presence of cirrhosis is recognized as an increased risk for hepatocellular carcinoma (HCC), and its onset is directly related to the degree of liver fibrosis. In the last decade, there has been the development and refinement of methods for predicting the degree of fibrosis and cirrhosis through noninvasive methods, with the aim of replacing liver biopsy. The population on the waiting list for liver transplantation has different degrees of liver fibrosis, which may not be directly related to MELD. In addition, these patients have HCC at the time of screening for liver transplantation. There is no evaluation of this population by elastography. The objective of this study was to evaluate patients undergoing screening for liver transplantation, with and without hepatocellular carcinoma, using liver elastography with Fibroscan® and ARFI. Elastography is an important non-invasive tool for monitoring severe cirrhosis and can aid in the management of hepatocellular carcinoma.
Product details
Binding:
Paperback
Number of Pages:
52
Release Date:
2025-10-18
Publication Date:
2025-10-18
Publisher:
Our Knowledge Publishing
Languages:
Original: English
ISBN10:
6209137830
ISBN13:
9786209137839
Weight:
96 g
Height:
150 cm
Width:
220 cm
Thickness:
4 cm
Buy on Amazon
Currently sold out